Evidence map›Paper›PMID 24940444›Full record

ArticleExperimental and therapeutic medicine2014

Gypenoside attenuates hepatic ischemia/reperfusion injury in mice via anti-oxidative and anti-apoptotic bioactivities.

Jie Zhao, Yingzi Ming, Qiquan Wan, Shaojun Ye, Song Xie, Yi Zhu, Yanfeng Wang, Zibiao Zhong, Ling Li, Qifa Ye

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Activity Components fromMolecules (Basel, Switzerland) · 2021
    Article
  10. The Protective Effect of Traditional Chinese Medicine on Liver Ischemia-Reperfusion Injury.Evidence-based complementary and alternative medicine : eCAM · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Anti-cancer effects ofChinese medicine · 2016
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jie ZhaoCenter of Transplant Medicine Engineering and Technology of the Ministry of Health of The People's Republic of China, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
Yingzi MingCenter of Transplant Medicine Engineering and Technology of the Ministry of Health of The People's Republic of China, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
Qiquan WanCenter of Transplant Medicine Engineering and Technology of the Ministry of Health of The People's Republic of China, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
Shaojun YeCenter of Transplant Medicine Engineering and Technology of the Ministry of Health of The People's Republic of China, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
Song XieCenter of Transplant Medicine Engineering and Technology of the Ministry of Health of The People's Republic of China, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
Yi ZhuCenter of Transplant Medicine Engineering and Technology of the Ministry of Health of The People's Republic of China, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China.
Yanfeng WangInstitute of Hepatobiliary Disease, Transplant Center, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430071, P.R. China.
Zibiao ZhongInstitute of Hepatobiliary Disease, Transplant Center, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430071, P.R. China.
Ling LiInstitute of Hepatobiliary Disease, Transplant Center, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430071, P.R. China.
Qifa YeCenter of Transplant Medicine Engineering and Technology of the Ministry of Health of The People's Republic of China, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China ; Institute of Hepatobiliary Disease, Transplant Center, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430071, P.R. China.
Third Xiangya Hospital · CNCentral South University · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apoptosisgypenosidehepatic injuryischemia/reperfusionoxidative damage

Identifiers

PMID24940444
PMCPMC3991488
OpenAlexW2021486875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.